These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2522822)

  • 21. In vitro immunomodulatory effects of placental substances on preparatory MLR and resulting modifications of lymphocyte reactivities.
    Duc HT; Righenzi S; Monnot P; Nakagawa S; Voisin GA
    J Reprod Immunol; 1987 Jul; 11(3):221-35. PubMed ID: 2958627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.
    Havele C; Paetkau V
    J Immunol; 1988 May; 140(10):3303-8. PubMed ID: 2966195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-7 mediates the generation and expansion of murine allosensitized and antitumor CTL.
    Jicha DL; Schwarz S; Mulé JJ; Rosenberg SA
    Cell Immunol; 1992 Apr; 141(1):71-83. PubMed ID: 1555257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin.
    Dziarski R
    J Immunol; 1989 Jul; 143(1):356-65. PubMed ID: 2471741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-2 and IL-4 can co-modulate the generation of cytotoxic T cells through CD8- CD4- splenic lymphocytes.
    Good MF; Powell LW; Halliday JW
    Immunology; 1989 Jun; 67(2):225-30. PubMed ID: 2568977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-gamma.
    Horvath-Arcidiacono JA; Mostowski HS; Bloom ET
    Int Immunol; 1996 May; 8(5):661-73. PubMed ID: 8671653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoactive products of placenta. IV. Impairment by placental cells and their products of CTL function at effector stage.
    Chaouat G; Kolb JP
    J Immunol; 1985 Jul; 135(1):215-22. PubMed ID: 2987345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asialo GM1 as an accessory molecule determining the function and reactivity of cytotoxic T lymphocytes.
    Hargrove ME; Ting CC
    Cell Immunol; 1988 Mar; 112(1):123-34. PubMed ID: 2449975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells.
    Roth AD; Dupuis S; Alberto P
    Clin Exp Immunol; 1995 Aug; 101(2):362-8. PubMed ID: 7648722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.
    Jin B; Scott JL; Vadas MA; Burns GF
    Immunology; 1989 Apr; 66(4):570-6. PubMed ID: 2541074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.
    Mellow L; Sabbadini E
    Immunology; 1985 Oct; 56(2):235-43. PubMed ID: 2932383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of IL-2 in vitro on CTL generation in spleen cells of young and old mice: asialo GM1+ cells are required for the apparent restoration of the CTL response.
    Bloom ET; Kubota LF
    Cell Immunol; 1989 Mar; 119(1):73-84. PubMed ID: 2784081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 3 augments the murine primary cytolytic T lymphocyte response to allogeneic tumor cells.
    Curtsinger JM; Fan DP
    J Immunol; 1984 Jul; 133(1):267-72. PubMed ID: 6427337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helper factor production in murine secondary syngeneic mixed leukocyte reactions.
    Zuberi RI; Altman A
    J Immunol; 1982 Feb; 128(2):817-22. PubMed ID: 6172511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
    Brooks CG; Holscher M; Urdal D
    J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
    Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoregulation by mouse T cell clones. III. Cloned H-Y-specific cytotoxic T cells secrete a soluble mediator(s) that inhibits cytotoxic responses by acting on both Lyt-2- and L3T4- lymphocytes.
    Simon MM; Nerz G; Prester M; Moll H
    Eur J Immunol; 1985 Aug; 15(8):773-83. PubMed ID: 2411568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen-independent activation of memory cytotoxic T cells by interleukin 2.
    Lefrancois L; Klein JR; Paetkau V; Bevan MJ
    J Immunol; 1984 Apr; 132(4):1845-50. PubMed ID: 6230394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.